Valuation : Square Pharmaceuticals PLC.

Market Cap 193B 1.57B 1.35B 1.27B 1.16B 2.18B 150B 2.19B 15.05B 5.87B 75.74B 5.89B 5.77B 251B P/E 2026 *
7.36x
P/E 2027 * 6.56x
Enterprise Value 193B 1.57B 1.35B 1.27B 1.16B 2.18B 150B 2.19B 15.05B 5.87B 75.74B 5.89B 5.77B 251B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.04x
Free-Float
55.9%
Yield 2026 *
-
Yield 2027 * -
1 week-0.41%
Current month-0.82%
1 month-0.14%
3 months+2.88%
6 months-3.46%
Current year+9.72%
1 week 217.4
Extreme 217.4
219.3
1 month 217.2
Extreme 217.2
221.5
Current year 198.1
Extreme 198.1
236
1 year 198
Extreme 198
236
3 years 197.2
Extreme 197.2
249.8
5 years 197.2
Extreme 197.2
251.9
10 years 149.05
Extreme 149.047619
278.67
Manager TitleAgeSince
Chief Executive Officer - 1994-12-31
Director of Finance/CFO - -
Compliance Officer - -
Director TitleAgeSince
Chairman - 2011-12-31
Director/Board Member - 1979-12-31
Director/Board Member - 2006-12-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.41%-2.11%+3.03% 1.57B
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -0.69%-2.26%+25.78%+44.24% 366.08B
Weighted average by Cap. -0.48%-3.29%+38.64%+65.49%

Financials

2026 *2027 *
Net sales 85.11B 692M 596M 559M 510M 961M 66.11B 964M 6.63B 2.59B 33.37B 2.6B 2.54B 111B 94.79B 770M 664M 622M 568M 1.07B 73.63B 1.07B 7.38B 2.88B 37.17B 2.89B 2.83B 123B
Net income 26.6B 216M 186M 175M 159M 300M 20.66B 301M 2.07B 809M 10.43B 812M 794M 34.58B 29.57B 240M 207M 194M 177M 334M 22.97B 335M 2.3B 899M 11.6B 902M 883M 38.45B
Net Debt - -
Logo Square Pharmaceuticals PLC.
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical manufacturer and exporter. Its core business activities include the manufacture and distribution of generic pharmaceutical products, basic chemical products, and animal health products. The Company operates in one segment: the business of developing, manufacturing, and marketing drugs for healthcare for all living species. It is also involved in the distribution of crop care products. The Company offers its products in several categories, including products listed by trade name, by therapeutic class, and by generic name. In addition to conventional pharmaceuticals, it also offers products under the Herbal & Nutraceuticals category, as well as AgroVet & Pesticides, which cover veterinary and agricultural chemical products. The Company’s manufacturing facilities are located in Pabna and Dhaka, Bangladesh. Its subsidiaries include Square Lifesciences Ltd., Square Pharmaceuticals Kenya EPZ Ltd., and Samson Pharma Inc.
Employees
15,937
Date Price Change Volume
26-08-27 BDT 217.90 0.00% 188,928
26-08-25 BDT 217.90 0.00% 124,095
26-08-24 BDT 217.90 -0.14% 245,429
26-08-23 BDT 218.20 -0.27% 264,035
26-08-20 BDT 218.80 0.00% 161,478
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
217.90BDT
Average target price
352.20BDT
Spread / Average Target
+61.63%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SQURPHARMA Stock